Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

A metric for the stiffness of calcified aortic valves using a combined computational and experimental approach.

Maleki H, Shahriari S, Durand LG, Labrosse MR, Kadem L.

Med Biol Eng Comput. 2014 Jan;52(1):1-8. doi: 10.1007/s11517-013-1113-y. Epub 2013 Sep 14.

PMID:
24037347
2.

Contrasting histoarchitecture of calcified leaflets from stenotic bicuspid versus stenotic tricuspid aortic valves.

Isner JM, Chokshi SK, DeFranco A, Braimen J, Slovenkai GA.

J Am Coll Cardiol. 1990 Apr;15(5):1104-8.

4.

Computational fluid dynamics simulation of transcatheter aortic valve degeneration.

Dwyer HA, Matthews PB, Azadani A, Jaussaud N, Ge L, Guy TS, Tseng EE.

Interact Cardiovasc Thorac Surg. 2009 Aug;9(2):301-8. doi: 10.1510/icvts.2008.200006. Epub 2009 May 4.

PMID:
19414489
5.

[The effect of electromagnetically produced shock waves on calcified, stenosed aortic valves].

Hartmann A, Rosenbohm GJ, Keul HG, Kober G, Satter P, Kaltenbach M.

Z Kardiol. 1990 Sep;79(9):610-4. German.

PMID:
2238771
6.

Balloon dilatation of calcific aortic stenosis in elderly patients: postmortem, intraoperative, and percutaneous valvuloplasty studies.

McKay RG, Safian RD, Lock JE, Mandell VS, Thurer RL, Schnitt SJ, Grossman W.

Circulation. 1986 Jul;74(1):119-25.

PMID:
2423269
8.

[Histopathologic features of degenerative aortic valve and its mechanisms].

Sun J, Meng DM, Jiang N, Wang LQ.

Zhonghua Yi Xue Za Zhi. 2013 Jan 22;93(4):280-4. Chinese.

PMID:
23578508
9.

Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study.

Novaro GM, Katz R, Aviles RJ, Gottdiener JS, Cushman M, Psaty BM, Otto CM, Griffin BP.

J Am Coll Cardiol. 2007 Nov 13;50(20):1992-8. Epub 2007 Oct 29.

10.

Cronic non-rheumatic valvular heart disease. An autopsy study.

Hallgrímsson J.

Acta Pathol Microbiol Scand A. 1976 May;84(3):247-52.

PMID:
1274589
11.

Insights into the use of biomarkers in calcific aortic valve disease.

Beckmann E, Grau JB, Sainger R, Poggio P, Ferrari G.

J Heart Valve Dis. 2010 Jul;19(4):441-52. Review.

12.

The 'valvulo-metabolic' risk in calcific aortic valve disease.

Mathieu P, Després JP, Pibarot P.

Can J Cardiol. 2007 Oct;23 Suppl B:32B-39B. Review. Erratum in: Can J Cardiol. 2009 Mar;25(3):140.

13.

Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies.

Freeman RV, Otto CM.

Circulation. 2005 Jun 21;111(24):3316-26. Review. No abstract available.

14.

Aortic valve sclerosis as a marker of active atherosclerosis.

Branch KR, O'Brien KD, Otto CM.

Curr Cardiol Rep. 2002 Mar;4(2):111-7. Review.

PMID:
11827633
15.

Expression and activity of matrix metalloproteinase-2 in calcific aortic stenosis.

Kaden JJ, Vocke DC, Fischer CS, Grobholz R, Brueckmann M, Vahl CF, Hagl S, Haase KK, Dempfle CE, Borggrefe M.

Z Kardiol. 2004 Feb;93(2):124-30.

PMID:
14963678
16.

Catheter-based intravascular ultrasound discriminates bicuspid from tricuspid valves in adults with calcific aortic stenosis.

Isner JM, Losordo DW, Rosenfield K, Ramaswamy K, Kelly S, Pastore JO, Kosowsky BD.

J Am Coll Cardiol. 1990 May;15(6):1310-7.

PMID:
2184185
17.

Osteopontin-CD44v6 interaction mediates calcium deposition via phospho-Akt in valve interstitial cells from patients with noncalcified aortic valve sclerosis.

Poggio P, Branchetti E, Grau JB, Lai EK, Gorman RC, Gorman JH 3rd, Sacks MS, Bavaria JE, Ferrari G.

Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):2086-94. doi: 10.1161/ATVBAHA.113.303017. Epub 2014 Jul 24.

18.

Bone regulatory factors NFATc1 and Osterix in human calcific aortic valves.

Alexopoulos A, Bravou V, Peroukides S, Kaklamanis L, Varakis J, Alexopoulos D, Papadaki H.

Int J Cardiol. 2010 Mar 4;139(2):142-9. doi: 10.1016/j.ijcard.2008.10.014. Epub 2008 Nov 18.

PMID:
19019468
19.

Noggin attenuates the osteogenic activation of human valve interstitial cells in aortic valve sclerosis.

Poggio P, Sainger R, Branchetti E, Grau JB, Lai EK, Gorman RC, Sacks MS, Parolari A, Bavaria JE, Ferrari G.

Cardiovasc Res. 2013 Jun 1;98(3):402-10. doi: 10.1093/cvr/cvt055. Epub 2013 Mar 12.

20.

VAP-1, Eotaxin3 and MIG as potential atherosclerotic triggers of severe calcified and stenotic human aortic valves: effects of statins.

Anger T, Pohle FK, Kandler L, Barthel T, Ensminger SM, Fischlein T, Weyand M, Stumpf C, Daniel WG, Garlichs CD.

Exp Mol Pathol. 2007 Dec;83(3):435-42. Epub 2007 Mar 24.

PMID:
17490641

Supplemental Content

Support Center